Please login to the form below

Not currently logged in
Email:
Password:

DH appoints chair of Monitor

The UK's Department of Health has appointed Dr David Bennett as chair of Monitor, the independent regulator of foundation trusts

The UK's Department of Health (DH) has appointed Dr David Bennett as chair of Monitor, the independent regulator of foundation trusts.

Dr Bennett currently holds the position of interim chief executive with the body, and will take over the role of chair from Steve Bundred.

The role of Monitor is proposed to change under the Health and Social Care Bill, with plans for the body to become economic regulator for all providers of health and adult social care services by 2013.

In this new role, Monitor would regulate pricing for NHS services; promote competition in healthcare services where appropriate; and to support GP consortia in ensuring essential services are maintained.

Dr Bennett, whose previous roles include non-political chief policy advisor to former Prime Minister Tony Blair and director at McKinsey & Co, described the successful implementation of the reforms as 'critical' with Monitor to play a key role in ensuring quality care.

Health Secretary Andrew Lansley commented on the appointment: "The new economic regulator will have a significantly different set of responsibilities from Monitor in its current form and, with his wealth of experience, I am confident that David will successfully lead the organisation through the changes ahead."

21st February 2011

From: Healthcare

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...

Infographics